Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
307 |
|
Actual shortage: | 12 (4%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 5 (2%) | |
Resolved: | 289 (94%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
48 (16%) |
|
Overdue reports |
5 (38%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2022-10-03 | 2023-04-03 | 170977 |
DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Actual shortage | 2023-06-02 | 2024-03-28 | 193649 |
KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2019-01-08 | 2019-01-19 | 71575 |
KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2019-01-22 | 2019-04-06 | 73209 |
KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2023-06-14 | 2023-08-01 | 194929 |
KETOROLAC TROMETHAMINE INJECTION, USP | 30MG | LIQUID | Resolved | 2024-01-31 | 2024-02-20 | 217938 |
INTRALIPID 20% | 20% | EMULSION | Resolved | 2021-09-10 | 2021-10-22 | 145481 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0